Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia
- 24 November 2004
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 7 (4) , 406-413
- https://doi.org/10.1111/j.1463-1326.2004.00410.x
Abstract
Aim: In this study, we investigated the association of plasma adiponectin and resistin concentrations with adipose tissue compartments in 41 free‐living men with a wide range of body mass index (22–35 kg/m2).Methods: Using enzyme immunoassays, plasma adiponectin and resistin were measured. Intraperitoneal, retroperitoneal, subcutaneous abdominal and posterior subcutaneous abdominal adipose tissue masses (IPATM, RPATM, SAATM and PSAATM, respectively) were determined using magnetic resonance imaging. Total adipose tissue mass (TATM) was measured using bioelectrical impedance. Insulin resistance was estimated with the help of homeostasis model assessment (HOMA) score.Results: In univariate regression, plasma adiponectin levels were inversely related to IPATM (r = −0.389, p < 0.05), SAATM (r = −0.500, p < 0.001), PSAATM (r = −0.502, p < 0.001), anterior SAATM (r = −0.422, p < 0.01) and TATM (r = −0.421, p < 0.01). In multiple regression models, adiponectin was chiefly correlated with PSAATM. Plasma adiponectin concentrations were also inversely correlated with HOMA score (r = −0.540, p < 0.001) and triglyceride (r = −0.632, p < 0.001), and positively correlated with high‐density lipoprotein cholesterol (r = 0.508, p < 0.001). There were no significant correlations between resistin levels and adipose tissue masses, insulin resistance or dyslipidaemia.Conclusions: In men, total body fat is significantly correlated with plasma adiponectin, but not with plasma resistin levels. Low plasma adiponectin levels appear to be chiefly determined by the accumulation of posterior subcutaneous abdominal fat mass, as opposed to intra‐abdominal fat, and are strongly predictive of insulin resistance and dyslipidaemia.Keywords
This publication has 38 references indexed in Scilit:
- Resistin: an adipocyte‐derived hormone. Has it a role in diabetes and obesity?Diabetes, Obesity and Metabolism, 2004
- Increased Resistin Gene and Protein Expression in Human Abdominal Adipose TissueJournal of Clinical Endocrinology & Metabolism, 2002
- -Adrenergic Regulation of IL-6 Release from Adipose Tissue: In Vivo and in Vitro StudiesJournal of Clinical Endocrinology & Metabolism, 2001
- Insulin Resistance and Type 2 Diabetes Are Not Related to Resistin Expression in Human Fat Cells or Skeletal MuscleBiochemical and Biophysical Research Communications, 2001
- Reduction in Visceral Adipose Tissue Is Associated with Improvement in Apolipoprotein B-100 Metabolism in Obese MenJournal of Clinical Endocrinology & Metabolism, 1999
- Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesityInternational Journal of Obesity, 1998
- Relationship of Anterior and Posterior Subcutaneous Abdominal Fat to Insulin Sensitivity in Nondiabetic MenObesity Research, 1997
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.Journal of Clinical Investigation, 1995
- Regional differences and effect of weight reduction on human fat cell metabolismEuropean Journal of Clinical Investigation, 1979